| J2323 | Injection, natalizumab, 1 mg | 1 | 10 | 800 | $6,250 | $5M |
| J2350 | Injection, ocrelizumab, 1 mg | 1 | 10 | 150 | $26,380 | $3.9M |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 4 | 10 | 360 | $430 | $1.1M |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 4 | 10 | 140 | $360 | $452K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 8 | 20 | 310 | $210 | $394.7K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 4 | 10 | 210 | $270 | $257.8K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 15 | 20 | 120 | $220 | $244.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 85 | 1,730 | 220 | $70 | $75.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,531 | 2,050 | 300 | $50 | $72.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 44 | 160 | 90 | $110 | $54.6K |